Rapid tranquilization: New approaches in the emergency treatment of behavioral disturbances

European Psychiatry

Volumn 19, Issue 5, 2004, Pages 243-249

  De Fruyt, Jürgen ^a,b   Demyttenaere, Koen ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^b General Hospital St Jan   (Belgium)

Author keywords

Agitation; Emergency psychiatry; Psychosis; Rapid tranquilization; Sedation; Violence

Indexed keywords

AMOBARBITAL; ATYPICAL ANTIPSYCHOTIC AGENT; BENZODIAZEPINE DERIVATIVE; CHLORPROMAZINE; CHOLINERGIC RECEPTOR BLOCKING AGENT; CLONAZEPAM; CLOTIAPINE; DIAZEPAM; DROPERIDOL; FLUNITRAZEPAM; HALOPERIDOL; LORAZEPAM; LOXAPINE; MIDAZOLAM; MOLINDONE; NEUROLEPTIC AGENT; NITRAZEPAM; OLANZAPINE; PARALDEHYDE; PHENOBARBITAL; PROMETHAZINE; QUETIAPINE; RISPERIDONE; TIOTIXENE; ZIPRASIDONE;

AGITATION; BEHAVIOR DISORDER; CLINICAL PRACTICE; CLINICAL TRIAL; DRUG DEPENDENCE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DYSTONIA; EMERGENCY HEALTH SERVICE; EMERGENCY TREATMENT; EVIDENCE BASED MEDICINE; EXTRAPYRAMIDAL SYMPTOM; HEART ARRHYTHMIA; HUMAN; MEASUREMENT; NOMENCLATURE; PARKINSONISM; PRIORITY JOURNAL; PSYCHOSIS; PUBLICATION; QT PROLONGATION; RESPIRATION DEPRESSION; REVIEW; SAMPLE SIZE; SEDATION; SIDE EFFECT; SLEEP;

EID: 3342893213     PISSN: 09249338     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eurpsy.2004.05.006     Document Type: Short Survey

References (58)

1. Agitation calmness scale. 1998;Eli Lilly and Company. Copyright
2. Allen M.H. Level 1 psychiatric emergency services. The tools of the crisis sector. Psychiatr Clin North Am. 22:1999;713-734
3. Allen M.H. Managing the agitated psychotic patient: a reappraisal of the evidence. J Clin Psychiatry. 61:(Suppl 14):2000;11-20
4. Allen M.H., Currier G.W., Hughes D.H., et al. The Expert Consensus Guideline Series: treatment of behavioral emergencies. Postgraduate Medicine Special Report. 2001;1-90
5. Atakan Z., Davies T. ABC of mental health. Mental health emergencies. BMJ. 314:1997;1740-1742
6. Battaglia J., Moss S., Rush J., Kang J., Mendoza R., Leedom L., et al. Haloperidol, lorazepam, or both for psychotic agitation? A multicenter, prospective, double-blind, emergency department study. Am J Emerg Med. 15:1997;335-340
7. Bellnier T.J. Continuum of care: stabilizing the acutely agitated patient. Am J Health-Syst Pharm. 59:(Suppl 5):2002;12-18
8. Bieniek S.A., Ownby R.L., Penalver A., Dominguez R.A. A double-blind study of lorazepam versus the combination of haloperidol and lorazepam in managing agitation. Pharmacotherapy. 18:1998;57-62
9. Binder R.L., McNeil D.E. Contemporary practices in managing acutely violent patients in 20 psychiatric emergency rooms. Psychiatr Serv. 50:1999;1553-1554
10. Breier A., Meehan K., Birkett M., David S., Ferchland, et al. A double-blind, placebo-controlled dose-response comparison of intramuscular olanzapine and haloperidol in the treatment of acute agitation in schizophrenia. Arch Gen Psychiatry. 59:2002;441-448
11. Breslow R.E., Klinger B.I., Erickson B.J. Acute intoxication and substance abuse among patients presenting to a psychiatric emergency service. Gen Hosp Psychiatry. 18:1996;183-191
12. Broadstock M. The effectiveness and safety of drug treatment for urgent sedation in psychiatric emergencies. A critical appraisal of the literature. N Z Health Technol Assess Clearing House Rep. 4:(1):2001
13. Brook S., Lucey J.V., Gunn K.P. for the Ziprasidone IM Study Group. Intramuscular ziprasidone compared with intramuscular haloperidol in the treatment of acute psychosis. J Clin Psychiatry. 61:2000;933-941
14. Canas F. Sustaining short-term gains for future progress. Int Clin Psychopharmacol. 16:(Suppl 1):2001;9-13
15. Corrigan J.D. Development of a scale for assessment of agitation following traumatic brain injury. J Clin Exp Neuropsychol. 11:1989;261-277
16. Cunnane J.G. Drug management of disturbed behaviour by psychiatrists. Psychiatr Bull. 18:1994;138-139
17. Currier G.W. Atypical antipsychotic medications in the psychiatric emergency service. J Clin Psychiatry. 61:(Suppl 14):2000;21-26
18. Currier GW, Allen MH. American Association for Emergency Psychiatry survey: I. Psychiatric emergency service structure and function. Presented at the Institute on Psychiatric Services, New Orleans, Oct 29-Nov 2, 1999.
19. Currier G.W., Simpson G.M. Risperidone liquid concentrate and oral lorazepam versus intramuscular haloperidol and intramuscular lorazepam for treatment of psychotic agitation. J Clin Psychiatry. 62:2001;153-157
20. Currier G.W., Trenton A. Pharmacological management of psychotic agitation. CNS Drugs. 16:2002;219-228
21. Daniel D.G., Potkin S.G., Reeves K.R., Swift R.H., Harrigan E.P. Intramuscular (IM) ziprasidone 20 mg is effective in reducing acute agitation associated with psychosis: a double-blind, randomized trial. Psychopharmacology. 155:2001;128-134
22. Dawes S.S., Bloniarz P.A., Mumpower J.L., et al. Supporting psychiatric assessments in emergency rooms. 1995;Center for Technology in Government, Albany (NY)
23. Donlon P.T., Hopkin J.T. Rapid "digitalization" of decompensated schizophrenic patients with antipsychotic drugs. Am J Psychiatry. 131:1974;310-312
24. Donlon P.T., Hopkin J.T., Tupin J.P., et al. Haloperidol for acute schizophrenic patients: an evaluation of three oral regimens. Arch Gen Psychiatry. 37:1980;691-695
25. Dubin W.R. Rapid tranquilization: antipsychotics or benzodiazepines? J Clin Psychiatry. 49:(Suppl 12):1988;5-11
26. Dubin W.R., Feld J.A. Rapid tranquilization of the violent patient. Am J Emerg Med. 7:1989;313-320
27. Dubin W.R., Waxman H.M., Weiss K.J., Ramchandani D., Tavani-Petroni C. Rapid tranquilization: the efficacy of oral concentrate. J Clin Psychiatry. 46:1985;475-478
28. Dubin W.R., Weiss K.J., Dorn J.M. Pharmacotherapy of psychiatric emergencies. J Clin Psychopharmacol. 6:1986;210-222
29. Fenton M., Coutinho E.S.F., Campbell C. Zuclopenthixol acetate in the treatment of acute schizophrenia and similar serious mental illnesses (Cochrane review). 2002;. The Cochrane library. No. 3. Oxford: Update Software
30. Forster P. Emergency psychiatry in a new mental health system: quality versus efficiency, structures versus networks. Presented at the Sixth World Congress of the International Association of Emergency Psychiatry, Barcelona, Jun 9-12, 2002.
31. Foster S., Kessel J., Brman M.E., Simpson G.M. Efficacy of lorazepam and haloperidol for rapid tranquilization in a psychiatric emergency room setting. Int Clin Psychopharmacol. 12:1997;175-179
32. Garza-Trevino E.S., Hollister L.E., Overall J.E., Alexander W.F. Efficacy of combinations of intramuscular antipsychotics and sedative-hypnotics for control of psychotic agitation. Am J Psychiatry. 146:1989;1598-1601
33. Hellewell J.S.E., Cameron-Hands D., Cantillon M. Seroquel: evidence for efficacy in the treatment of hostility and aggression. Schizophr Res. 29:1998;154-155
34. Hillard J.R. Emergency treatment of acute psychosis. J Clin Psychiatry. 59:(Suppl 1):1998;57-60
35. Huf G., et al. Current practices in managing acutely disturbed patients at three hospitals in Rio de Janeiro-Brazil: a prevalence study. BMC Psychiatry. 2:2002;4
36. Kamin J., Manwani S., Hughes D. Extrapyramidal side effects in the psychiatric emergency service. Psychiatr Serv. 51:2000;287-289
37. Karagianis J.L., Dawe I.C., Thakur A., Begin S., Raskin J., Roychowdhury S.M., et al. Rapid tranquilization with olanzapine in acute psychosis: a case series. J Clin Psychiatry. 62:(Suppl 2):2001;12-16
38. Kay S.R., Fiszbein A., Opler L.A. The positive and negative scale (PANSS) for schizophrenia. Schizophr Bull. 13:1987;261-276
39. Kerr I.B., Taylor D. Acute disturbed or violent behaviour: principles of treatment. J Psychopharmacol. 11:1997;271-277
40. Lesem M.D., Zajecka J.M., Swift R.H., Reeves K.R., Harrigan E.P. Intramuscular ziprasidone, 2 mg versus 10 mg, in the short-term management of agitated psychotic patients. J Clin Psychiatry. 62:2001;12-18
41. Lindenmayer J.P. The pathophysiology of agitation. J Clin Psychiatry. 61:(Suppl 14):2000;5-10
42. Marson D.C., McGovern M.P., Pomp H.C. Psychiatric decision making in the emergency room: a research overview. Am J Psychiatry. 145:1988;918-925
43. McAllister-Williams H.R., Ferrier N.I. Rapid tranquillisation: time for a reappraisal of options for parenteral therapy. Br J Psychiatry. 179:2001;485-489
44. Neborsky R., Janowsky D., Munson E., et al. Rapid treatment of acute psychotic symptoms with high- and low-dose haloperidol. Arch Gen Psychiatry. 38:1981;195-199
45. Overall J.E., Gorham D.R. The brief psychiatric rating scale. Psychol Rep. 10:1962;799-812
46. Pilowsky L.S., Ring H., Shine P.J., Battersby M., Lader M. Rapid tranquillisation. A survey of emergency prescribing in a general psychiatric hospital. Br J Psychiatry. 160:1992;831-835
47. Raja M., Azzoni A. Second-generation antipsychotics in the emergency care setting. A prospective naturalistic study. Gen Hosp Psychiatry. 22:2000;101-114
48. c-interval abnormalities and psychotropic drug therapy in psychiatric patients. Lancet. 355:2000;1048-1052
49. Resnick M., Burton B.T. Droperidol vs haloperidol in the initial management of acutely agitated patients. J Clin Psychiatry. 45:1984;298-299
50. Rothschild A.J. Disinhibition, amnestic reactions, and other adverse reactions secondary to triazolam: a review of the literature. J Clin Psychiatry. 53:(12, Suppl):1992;69-79
51. Sailas E., Fenton M. Seclusion and restraint for people with serious mental illnesses (Cochrane review). 2002;. The Cochrane library. No. 3. Oxford: Update Software
52. Salzman C., Solomon D., Miyawaki E., Glassman R., Rood L., Flowers E., et al. Parenteral lorazepam versus parenteral haloperidol for the control of psychotic disruptive behavior. J Clin Psychiatry. 52:1991;177-180
53. Sheline Y., Nelson T. Patient choice: deciding between psychotropic medication and physical restraints in an emergency. Bull Am Acad Psychiatry Law. 21:1993;321-329
54. Swift R.H., Harrigan E.P., Cappelleri J.C., Kramer D., Chandler L.P. Validation of the behavioural activity rating scale (BARS)™: a novel measure of activity in agitated patients. J Psych Res. 36:2002;87-95
55. Thomas H. Jr, Schwartz E., Petrilli R. Droperidol versus haloperidol for chemical restraint of agitated and combative patients. Ann Emerg Med. 21:1992;407-413
56. Wing J., Marriott S., Palmer C., Thomas V. Management of imminent violence: clinical practice guidelines to support mental health services. R Coll Psychiatrists. 41:1998;1-111. [Occasional paper]
57. Wright P., Birkett M., David S.R., Meehan K., Ferchland I., et al. Double-blind, placebo-controlled comparison of intramuscular olanzapine and intramuscular haloperidol in the treatment of acute agitation in schizophrenia. Am J Psychiatry. 158:2001;1149-1151
58. Yudofsky S.C., Silver J.M., Jackson W., Endicott J., Williams D. The overt aggression scale for the objective rating of verbal and physical aggression. Am J Psychiatry. 143:1986;35-39